# DESCRIPTION

## FIELD

- define field of disclosure

## BACKGROUND

- introduce babesiosis
- describe transmission and prevalence
- discuss public health risk
- mention lack of well-characterized antigens

## SUMMARY

- introduce immunodominant antigens
- describe identification method
- summarize use in immunological assays
- outline methods for detecting antibodies
- mention kits and compositions

## DETAILED DESCRIPTION

### I. Abbreviations

- define abbreviations

### II. Terms and Methods

- define antibody
- describe antibody structure
- explain antibody function
- define antigen
- describe antigen function
- define babesia microti
- describe babesia microti serine rich antigen
- provide sequence information for BmSERA
- define babesia microti maltese cross form related protein
- provide sequence information for BmMCFRP
- define babesia microti piroplasma 1-strand domain
- provide sequence information for BmPiPS
- define babesiosis
- describe symptoms of babesiosis
- define biological sample
- provide examples of biological samples
- define conjugated
- explain contacting
- define control
- provide examples of controls
- define fluorescent protein
- provide examples of fluorophores
- define fusion protein
- explain how to create a fusion protein
- define heterologous
- define isolated
- explain how to isolate biological components
- define label
- provide examples of labels
- explain labeling
- define operably linked
- explain operable linkage
- define polypeptide
- explain conservative substitutions
- provide examples of conservative substitutions
- define purified
- explain purification
- define secondary antibody
- explain sequence identity
- explain sequence similarity
- describe methods of sequence alignment
- define serum
- define solid support
- define subject

### III. Introduction

- introduce phage display technique
- describe B. microti phage display library construction
- identify immunodominant B. microti antigens
- summarize diagnostic potential of identified antigens

### IV. Overview of Several Embodiments

- introduce immunodominant B. microti antigens
- describe method for detecting B. microti-specific antibodies
- outline method for diagnosing B. microti infection
- specify antigenic polypeptides for detection method
- provide examples of antigenic polypeptides
- describe secondary antibody conjugation
- outline detection methods for antigen-antibody complexes
- specify labels for detection
- describe enzyme-linked detection
- specify fluorescent protein detection
- describe biological samples for detection
- outline treatment of B. microti infection
- specify treatment options
- introduce kits for detection and diagnosis
- describe kit components
- specify antigenic polypeptides for kits
- provide examples of antigenic polypeptides for kits
- describe immobilization of antigenic polypeptides
- specify solid supports for kits
- introduce fusion proteins
- describe heterologous peptides for fusion proteins
- specify affinity tags for fusion proteins
- specify epitope tags for fusion proteins
- specify fluorescent tags for fusion proteins
- specify carrier proteins for fusion proteins
- describe compositions with immobilized antigenic polypeptides
- specify solid supports for compositions
- introduce isolated nucleic acid molecules
- describe nucleotide sequences of isolated nucleic acid molecules
- introduce vectors with isolated nucleic acid molecules
- describe isolated polypeptides and nucleic acid molecules encoding them

### V. Detection of Babesia microti Antibodies in Patient Samples and Donor Blood

- disclose serological methods
- introduce immunodominant B. microti antigenic polypeptides
- describe detection assays
- motivate ELISA
- describe indirect ELISA
- introduce ECL-ELISA
- outline ECL-ELISA protocol
- motivate IgM or IgG antibody capture ELISAs
- describe IgM antibody capture ELISA
- describe IgG antibody capture ELISA
- motivate sandwich ELISA
- describe sandwich ELISA
- motivate microsphere immunoassay
- describe microsphere immunoassay
- motivate lateral flow assay
- describe lateral flow assay
- outline LFA design
- describe direct sandwich assays
- describe competitive assays
- introduce examples

## EXAMPLES

### Example 1: Materials and Methods

- describe B. microti parasites
- isolate infected red blood cells
- construct B. microti cDNA phage library
- prepare B. microti RNA
- synthesize cDNA
- fragment cDNA
- ligate cDNA into phage vector
- transform E. coli cells
- select recombinants
- recover phages
- determine phage titer
- express cDNA inserts
- sequence cDNA inserts
- immunoscreen via panning
- coat plates with anti-human IgG Fcγ antibodies
- block plates with BSA
- add babesiosis patient sera
- add phages
- wash and elute phages
- amplify and sequence phage clones
- analyze phage ELISA results
- express and purify recombinant B. microti antigens
- generate antibodies against recombinant antigens
- perform ELISA and immunofluorescence assays

### Example 2: ECL-ELISA for the Detection of Antibodies to B. microti in Blood Donors

- describe ELISA development
- immunoscreen B. microti antigens
- identify immunodominant B. microti antigens
- analyze gene sequences
- identify 56 immunodominant B. microti antigens
- select 30 high ELISA reactive phage clones
- characterize antigenic properties
- analyze gene distribution on chromosomes
- identify unique antigens
- analyze protein sequences
- identify orthologs in other apicomplexans
- express recombinant proteins
- analyze protein domains
- predict signal peptides
- analyze transmembrane regions
- analyze low complexity regions
- identify evolutionary relationships
- analyze BmR1_04g08155 protein
- analyze BmR1_03g04855 protein
- identify BMN1 antigen family
- analyze phylogenetic relationships
- identify PiβS domain
- analyze BmR1_02g04285 protein
- characterize recombinant antigens
- analyze protein purity
- evaluate ELISA reactivity
- identify immunodominant antigens
- combine antigens for enhanced sensitivity
- determine specificity
- claim invention scope

